ArchiMed

Q: When was ArchiMed last fund created?

ArchiMed last fund was created/launched in 2014-12-10.

General contacts

Investor type

Founded

2014

AUM

$9 000 M

Location

New York, New York, United States

Investment Ticket

$50-100 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

Europe North America

ESG Focus

Impact investor

Investor profile last updated: 16 August, 2026

Profile

ArchiMed is a healthcare-focused private equity investor based in Europe, established by healthcare professionals. The firm consists of over 160 professionals, including finance experts, scientists, and operational managers. They distinguish themselves by accelerating the development of healthcare industries and solutions that benefit people and patients around the world. ArchiMed is known for its team’s ability to leverage their scientific and operational expertise to foster growth in their portfolio companies.

ArchiMed invests exclusively in the healthcare sector, covering sub-sectors such as pharmaceuticals, medical devices, and healthcare services. The firm generally targets leveraged buyouts with check sizes typically in the $50-100 million range. The structured stages include acquisitions, and series B investments within North America and Europe. They manage several funds, including the MED Platform I and MED Platform II funds, summing up to significant assets under management.

Notable investments include Esperion Therapeutics - biopharmaceuticals, Cardioline - cardiovascular monitoring, Corealis - pharmaceutical solutions, and IRAB - science and technology development. Their strategic acquisitions and impactful healthcare investments emphasize their prowess in the sector.

Industry

Life Sciences MedTech LegalTech HealthTech Biotechnology Business Services (B2B) Education Edtech Financial Services Fintech Healthcare Services Medical Devices Pharmaceuticals SaaS Software Transportation Security Foodtech Food and Beverage

ArchiMed Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
MED I	Private Equity (PE)	Financial Services Fintech Healthcare Services SaaS Software HealthTech	Series B Late Stage (Series C+)	North America Europe	$5-10 m	$155 M	December 2014
MED Platform II Fund	Private Equity (PE)	Biotechnology Healthcare Services Medical Devices Pharmaceuticals HealthTech	Series B Late Stage (Series C+)	North America Europe	$50-100 m	—	September 2026
MED Platform II	Private Equity (PE)	Transportation Software Security Pharmaceuticals Medical Devices Healthcare Services Foodtech Food and Beverage Fintech Financial Services Edtech Education Business Services (B2B) Biotechnology HealthTech LegalTech MedTech	Series B Late Stage (Series C+)	Europe North America	$50-100 m	$3500 M	June 2023

Contacts

Name

Title

Social Networks

Vincent Guillaumot Managing Partner

Managing Partner

v•••@•••

Denis Ribon Chairman, Managing Partner

Chairman, Managing Partner

d•••@•••

Upgrade to see contacts

yrVSdcuAsant1mEW yrVSdcuAsant1mEW

yrVSdcuAsant1mEW

[email protected]

yrVSdcuAsant1mEW yrVSdcuAsant1mEW

yrVSdcuAsant1mEW

[email protected]

yrVSdcuAsant1mEW yrVSdcuAsant1mEW

yrVSdcuAsant1mEW

[email protected]

Investment-team contacts for ArchiMed — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about ArchiMed

Is ArchiMed a venture capital or private equity firm?

ArchiMed is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $50-100 m.

Where is ArchiMed located?

ArchiMed is located in New York, New York, United States.

When was ArchiMed founded?

ArchiMed was founded in 2014.

What sectors and industries does ArchiMed invest in?

ArchiMed invests in companies and startups in Life Sciences, MedTech, LegalTech, HealthTech, Biotechnology, Business Services (B2B), Education, Edtech, Financial Services, Fintech, Healthcare Services, Medical Devices, Pharmaceuticals, SaaS, Software, Transportation, Security, Foodtech, Food and Beverage.

What is ArchiMed geographical focus of investments?

ArchiMed invests in companies and startups in Europe, North America.

At what stages of companies and startups does ArchiMed typically invest in?

ArchiMed invests in companies and startups at Series B, Late Stage (Series C+).

What is the usual amount of ArchiMed investment?

ArchiMed usually invests $50-100 m on average.

What is the amount of assets of under management (AUM) for ArchiMed?

ArchiMed has around $9 000m assets under management.

When was ArchiMed last fund created?

ArchiMed last fund was created/launched in 2014-12-10

Is ArchiMed impact investor?

Yes, ArchiMed is impact investor.

What are the contacts of ArchiMed?

ArchiMed can be reached through its website archimed.group and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for ArchiMed — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access ArchiMed data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query ArchiMed directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the ArchiMed profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.